With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.
Trump
Administration
Supported by
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.
By Christina Jewett
A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and…
Monitoring trials in real time may help shorten the time interval between trial phases.
Basia Sall, chief data officer and deputy chief AI officer at the Nuclear Regulatory Commission, said on Thursday that the…
The order asks artificial intelligence companies to give the U.S. government 30 days to assess frontier models before they are…
The move aims to tamp down risks of fraud and save money
